You're not alone: the York Region has a vibrant Crohn’s and colitis community, made up of people with inflammatory bowel disease, families, volunteers, and more. Throughout the year, we come together at meetings and events like the Gutsy Walk to share experiences, raise funds and heighten awareness.

There are an estimated 7,000 people with Crohn’s disease or ulcerative colitis in the York Region community. We understand the challenges you and your family may be facing – because we face them, too.
Runners at the 2025 Toronto Waterfront Marathon

2025 Toronto Waterfront Marathon

Crohn’s and Colitis Canada is once again an official charity partner of the Toronto Waterfront Marathon! Whether you’re a seasoned runner, a casual walker, or simply looking to support a ...

 • 
5K Start Line Location: University Ave between Armoury St. and King St. Marathon and Half Marathon Start Line Location: University Ave between Armoury St & King St
Toronto
 • 
Gutsy Learning Sereies logo on background of a public speaker

Navigating Crohn's and colitis in the Workplace: Empowering Tools for Disclosure and Accommodations

The Gutsy Learning Series (GLS) offers a unique opportunity to learn directly from Canada’s leading experts in inflammatory bowel disease (IBD). Whether you're living with Crohn’s ...

 • 
Virtual
 • 

Facebook

More on Facebook
 
Remember to bookmark this page.

News

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

 19 20 21 22 23 24 25 26 27 28